Literature DB >> 12719601

Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization.

Yoshio Hashimoto1, Horng-Shen Chen, Cynthia Cunningham, Tahir H Malik, Patrick K Lai.   

Abstract

Borna disease virus (BDV) infection of Lewis rats is the most studied animal model of Borna disease, an often fatal encephalomyelitis. In this experimental model, BDV-specific CD8(+) cytotoxic T lymphocytes (CTLs) play a prominent role in the immunopathogenesis of infection by the noncytolytic, persistent BDV. Of the six open reading frames of BDV, CTLs to BDV X (p10) and the L-polymerase have never been studied. In this study, we used plasmid immunization to investigate the CTL response to BDV X and N. Plasmid-based immunization was a potent CTL inducer in Lewis rats. Anti-X CTLs were primed by a single injection of the p10 cDNA. Two codominant p10 epitopes, M(1)SSDLRLTLL(10) and T(8)LLELVRRL(16), associated with the RT1.A(l) major histocompatibility complex class I molecules of the Lewis rats, were identified. In addition, immunization with a BDV p40-expressing plasmid confirmed the previously reported RT1.A(l)-restricted A(230)SYAQMTTY(238) peptide as the CTL target for BDV N. In contrast to the CTL responses, plasmid vaccination was a poor inducer of an antibody response to p10. Three injections of a recombinant eukaryotic expression plasmid of BDV p10 were needed to generate a weak anti-p10 immunoglobulin M response. However, the antibody response could be optimized by a protein boost after priming with cDNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719601      PMCID: PMC154008          DOI: 10.1128/jvi.77.10.6076-6081.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.

Authors:  K Chan; D J Lee; A Schubert; C M Tang; B Crain; S P Schoenberger; M Corr
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

2.  Nuclear localization of the protein from the open reading frame x1 of the Borna disease virus was through interactions with the viral nucleoprotein.

Authors:  T H Malik; T Kobayashi; M Ghosh; M Kishi; P K Lai
Journal:  Virology       Date:  1999-05-25       Impact factor: 3.616

3.  Characterization of the P protein-binding domain on the 10-kilodalton protein of Borna disease virus.

Authors:  T H Malik; M Kishi; P K Lai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.

Authors:  H T Maecker; D T Umetsu; R H DeKruyff; S Levy
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

5.  Isolation of Borna disease virus from human brain tissue.

Authors:  Y Nakamura; H Takahashi; Y Shoya; T Nakaya; M Watanabe; K Tomonaga; K Iwahashi; K Ameno; N Momiyama; H Taniyama; T Sata; T Kurata; J C de la Torre; K Ikuta
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

Authors:  M L Albert; B Sauter; N Bhardwaj
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

7.  Nuclear targeting activity associated with the amino terminal region of the Borna disease virus nucleoprotein.

Authors:  T Kobayashi; Y Shoya; T Koda; I Takashima; P K Lai; K Ikuta; M Kakinuma; M Kishi
Journal:  Virology       Date:  1998-03-30       Impact factor: 3.616

8.  Effect of immune priming on Borna disease.

Authors:  A J Lewis; J L Whitton; C G Hatalski; H Weissenböck; W I Lipkin
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.

Authors:  O Planz; L Stitz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Borna disease in a dog with lethal meningoencephalitis.

Authors:  H Weissenböck; N Nowotny; P Caplazi; J Kolodziejek; F Ehrensperger
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

View more
  2 in total

1.  Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant.

Authors:  Marco Henkel; Oliver Planz; Timo Fischer; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Constitutive activation of the transcription factor NF-kappaB results in impaired borna disease virus replication.

Authors:  Soizic Bourteele; Katja Oesterle; Stephan Pleschka; Gunhild Unterstab; Christina Ehrhardt; Thorsten Wolff; Stephan Ludwig; Oliver Planz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.